Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

49.30
BATS BZX Real-Time Price
As of 2:44pm ET
 -1.34 / -2.65%
Today’s Change
48.61
Today|||52-Week Range
85.83
-1.04%
Year-to-Date
The 10 Worst Stocks in the S&P 500 in 2016
Jan 08 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close50.64
Today’s open50.07
Day’s range49.09 - 50.07
Volume123,431
Average volume (3 months)1,945,179
Market cap$5.4B
Dividend yield--
Data as of 2:44pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.67%
Revenue growth (last year)+1.01%
P/E ratio11.3
Price/Sales2.30
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+0.04+0.23%
OPKOPKO Health Inc-0.24-2.62%
IONSIonis Pharmaceutical...-2.05-4.26%
GRFSGrifols SA-0.11-0.65%
Data as of 2:45pm ET, 01/17/2017

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)$1.70
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts


Search for Jobs